Children with severe early-onset epilepsy may face a deeper cellular disruption than previously understood. Rather than simply producing defective brain channels, certain genetic mutations appear to fundamentally misplace critical electrical components within neurons, creating a cascade of developmental problems that standard treatments might not address effectively. This cellular geography problem could explain why some young patients experience such devastating neurological outcomes despite having channels that retain partial function. The H228R mutation in the KCNQ2 potassium channel gene demonstrates this phenomenon clearly. When researchers examined brain tissue from genetically modified mice carrying this human disease variant, they discovered that mutated channels accumulated incorrectly in neuronal cell bodies instead of traveling to their proper positions along axons where electrical signaling occurs. This misplacement represents a distinct disease mechanism beyond the loss of channel function that scientists typically focus on when studying epilepsy genetics. The trafficking defect appears particularly insidious because it doesn't completely eliminate channel activity but rather redistributes it to cellular locations where it cannot properly regulate neuronal excitability. Some mice carrying this mutation died prematurely despite having hippocampal neurons that showed normal intrinsic electrical properties, suggesting the cellular mislocalization creates problems that extend beyond simple hyperexcitability. This finding challenges the conventional approach to treating KCNQ2-related epilepsies, which primarily targets channel function rather than cellular targeting mechanisms. Future therapeutic strategies may need to address both the biophysical properties of mutated channels and their ability to reach appropriate cellular destinations, potentially requiring combination approaches that enhance both channel function and intracellular trafficking pathways.